451625778	451625778	CD	B-NP	O
|	|	NN	I-NP	O
RCACH	RCACH	NN	I-NP	O
|	|	NN	I-NP	O
35554141	35554141	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1207748	1207748	CD	B-NP	O
|	|	CC	I-NP	O
3/18/2007	3/18/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Pneumonia	Pneumonia	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/29/2007	5/29/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/26/2007	7/26/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
JUETT	JUETT	NNP	B-NP	O
,	,	,	O	O
OLLIE	OLLIE	NNP	B-NP	O
342-55-89-2	342-55-89-2	CD	I-NP	O
Lare	Lare	NNP	I-NP	O
Ly	Ly	NNP	I-NP	O
Kanlene	Kanlene	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
2/19/07	2/19/07	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GADSEN	GADSEN	NNP	B-NP	O
,	,	,	O	O
RICH	RICH	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

GLYBURIDE	GLYBURIDE	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

LISINOPRIL	LISINOPRIL	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

METOPROLOL	METOPROLOL	NNP	B-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	B-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

METFORMIN	METFORMIN	NN	B-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

ALENDRONATE	ALENDRONATE	NNP	B-NP	O
UNKNOWN	UNKNOWN	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QWEEK	QWEEK	NNP	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

ROSIGLITAZONE	ROSIGLITAZONE	NN	B-NP	O
4	4	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
INHALER	INHALER	NN	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
February	February	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
instruct	instruct	NN	B-NP	O
pt	pt	NN	I-NP	O
how	how	WRB	B-ADVP	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
with	with	IN	B-PP	O
spacer	spacer	NN	B-NP	B-protein
FOSAMAX	FOSAMAX	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ALENDRONATE	ALENDRONATE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
70	70	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QWEEK	QWEEK	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
Take	Take	NN	I-NP	O
with	with	IN	B-PP	O
8	8	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
plain	plain	JJ	B-NP	O
water	water	NN	I-NP	O
AZITHROMYCIN	AZITHROMYCIN	NN	I-NP	O
250	250	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
February	February	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
antacids	antacid	NNS	I-NP	O
Take	Take	VBP	B-VP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/22/07	2/22/07	CD	B-NP	O
by	by	IN	B-PP	O
LOW	LOW	NNP	B-NP	O
,	,	,	O	O
KENETH	KENETH	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
AZITHROMYCIN	AZITHROMYCIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
AZITHROMYCIN	AZITHROMYCIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
GLYBURIDE	GLYBURIDE	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/19/07	2/19/07	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
GLYBURIDE	GLYBURIDE	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	O
860800418	860800418	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
FUROSEMIDE	FUROSEMIDE	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Rash	Rash	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
takes	take	VBZ	B-VP	O
regularly	regularly	RB	B-ADVP	O
ROBITUSSIN	ROBITUSSIN	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
GUAIFENESIN	GUAIFENESIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	B-NP	O
MILLILITERS	MILLILITERS	NNS	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Other	Other	JJ	B-ADJP	O
:	:	:	O	O
Cough	Cough	IN	B-PP	O
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/22/07	2/22/07	CD	B-NP	O
by	by	IN	B-PP	O
BEETLEY	BEETLEY	NNP	B-NP	O
,	,	,	O	O
DILLON	DILLON	NNP	B-NP	O
D.	D.	NNP	I-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
715784488	715784488	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
FUROSEMIDE	FUROSEMIDE	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Rash	Rash	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
takes	take	VBZ	B-VP	O
regularly	regularly	RB	B-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/22/07	2/22/07	CD	B-NP	O
by	by	IN	B-PP	O
MEMMOTT	MEMMOTT	NNP	B-NP	O
,	,	,	O	O
KOREY	KOREY	NNP	B-NP	O
L.	L.	NNP	I-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
374710599	374710599	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/22/07	2/22/07	CD	B-NP	O
by	by	IN	B-PP	O
BOCKOVEN	BOCKOVEN	NNP	B-NP	O
,	,	,	O	O
DON	DON	NNP	B-NP	O
C.	C.	NNP	I-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
312726310	312726310	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
METFORMIN	METFORMIN	NN	B-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
AVANDIA	AVANDIA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ROSIGLITAZONE	ROSIGLITAZONE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
4	4	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
ZOCOR	ZOCOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/22/07	2/22/07	CD	B-NP	O
by	by	IN	B-PP	O
GREAR	GREAR	NN	B-NP	B-protein
,	,	,	O	O
PHIL	PHIL	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
AZITHROMYCIN	AZITHROMYCIN	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
116960379	116960379	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
AZITHROMYCIN	AZITHROMYCIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
AZITHROMYCIN	AZITHROMYCIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Your	Your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Haeussler	Haeussler	NNP	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
FUROSEMIDE	FUROSEMIDE	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Dyspnea	Dyspnea	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pneumonia	Pneumonia	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
aortic	aortic	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
aortic	aortic	JJ	I-NP	B-protein
stenosis	stenosis	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
diabetes	diabete	VBZ	B-VP	O
-LRB-	-LRB-	NN	B-NP	B-protein
diabetes	diabetes	NN	I-NP	I-protein
mellitus	mellitus	NN	I-NP	I-protein
type	type	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
sleep	sleep	NN	I-NP	I-protein
apnea	apnea	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
sleep	sleep	NN	I-NP	I-protein
apnea	apnea	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
pace	pace	NN	I-NP	I-protein
maker	maker	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
pacemaker	pacemaker	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
sick	sick	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
rhtyhm	rhtyhm	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
sick	sick	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
75	75	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
h/o	h/o	NN	I-NP	O
AS	AS	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
SSS	SSS	NN	B-NP	O
s/p	s/p	NN	I-NP	O
PM	PM	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
restrictive	restrictive	JJ	B-NP	O
lung	lung	NN	I-NP	O
dz	dz	NN	I-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
productive	productive	JJ	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
USOH	USOH	NN	B-NP	O
until	until	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
when	when	WRB	B-ADVP	O
pt	pt	NN	B-NP	O
developed	develop	VBD	B-VP	O
dry	dry	JJ	B-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
cough	cough	NN	I-NP	O
worsened	worsen	VBD	B-VP	O
producing	produce	VBG	I-VP	O
green	green	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
of	of	IN	B-PP	O
101	101	CD	B-NP	O
F	F	NN	I-NP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
PTA	PTA	NN	I-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
wheezing	wheezing	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
increasing	increase	VBG	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
any	any	DT	B-NP	O
N/V/D	N/V/D	NN	I-NP	B-protein
,	,	,	O	O
sore	sore	NN	B-NP	O
throat	throat	NN	I-NP	O
,	,	,	O	O
sick	sick	JJ	B-NP	O
contacts	contact	NNS	I-NP	O
,	,	,	O	O
or	or	CC	O	O
exposures	exposure	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
associated	associate	VBN	I-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
light	light	JJ	B-NP	O
headedness	headedness	NN	I-NP	O
,	,	,	O	O
headaches	headache	NNS	B-NP	O
,	,	,	O	O
photophobia	photophobia	NN	B-NP	O
,	,	,	O	O
edema	edema	NN	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
sleep	sleep	NN	B-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
flu	flu	NN	I-NP	O
vaccine	vaccine	NN	I-NP	O
this	this	DT	B-NP	O
year	year	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
made	make	VBD	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
today	today	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
heard	hear	VBD	B-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
phone	phone	NN	I-NP	O
he	he	PRP	B-NP	O
told	tell	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
him	him	PRP	B-NP	O
first	first	JJ	B-NP	O
thing	thing	NN	I-NP	O
this	this	DT	B-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
appointment	appointment	NN	I-NP	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
an	an	DT	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
workup	workup	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
worsening	worsen	VBG	I-NP	O
SOB	SOB	NN	I-NP	B-protein
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
patient	patient	NN	I-NP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
4	4	CD	B-NP	O
falls	fall	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
2	2	CD	I-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
recently	recently	RB	I-ADVP	O
1	1	CD	B-NP	O
month	month	NN	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

And	And	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
workup	workup	NN	I-NP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
,	,	,	O	O
pulmonologist	pulmonologist	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
cardiologist	cardiologist	NN	B-NP	O
.	.	.	O	O

ED	ED	VBN	B-VP	O
:	:	:	O	O
In	In	IN	B-PP	O
ED	ED	JJ	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
Temp	Temp	NNP	B-NP	O
98.5	98.5	CD	I-NP	O
and	and	CC	O	O
tachypneic	tachypneic	JJ	B-NP	O
breathing	breathing	NN	I-NP	O
at	at	IN	B-PP	O
28/min	28/min	NN	B-NP	O
sating	sate	VBG	B-VP	O
88	88	CD	B-NP	O
%	%	NN	I-NP	O
at	at	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
and	and	CC	O	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
4L	4L	NN	B-NP	O
NC	NC	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
hemodynamically	hemodynamically	RB	B-NP	O
stable	stable	JJ	I-NP	O
HR	HR	NN	I-NP	B-DNA
96	96	CD	I-NP	I-DNA
BP	BP	NN	I-NP	I-DNA
130/70	130/70	CD	I-NP	I-DNA
.	.	.	O	O

Labs	Lab	NNS	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
D	D	NN	I-NP	O
dimmer	dimmer	NN	I-NP	O
of	of	IN	B-PP	O
540	540	CD	B-NP	O
and	and	CC	O	O
PE-CT	PE-CT	NN	B-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	O
and	and	CC	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
and	and	CC	I-NP	O
azithromycin	azithromycin	NN	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
duonebx3	duonebx3	NN	B-NP	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
of	of	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
.	.	.	O	O

ROS	ROS	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
denies	deny	VBZ	B-VP	O
anorexia	anorexia	NN	B-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
travel	travel	NN	I-NP	O
,	,	,	O	O
change	change	NN	B-NP	O
in	in	IN	B-PP	O
medications	medication	NNS	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
CARDS	CARDS	NN	B-NP	O
HX	HX	NN	I-NP	O
:	:	:	O	O
Aortic	Aortic	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
DM2	DM2	NN	B-NP	B-protein
,	,	,	O	O
SSS	SSS	NN	B-NP	O
s/p	s/p	NN	I-NP	O
PM	PM	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
elective	elective	JJ	B-NP	O
cath	cath	NN	I-NP	O
performed	perform	VBN	B-VP	O
on	on	IN	B-PP	O
4/9	4/9	CD	B-NP	O
showed	show	VBD	B-VP	O
minimal	minimal	JJ	B-NP	O
CAD	CAD	NN	I-NP	O
and	and	CC	O	O
mildly	mildly	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
gradient	gradient	NN	I-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
OTHER	OTHER	NN	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
Sleep	Sleep	NN	B-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
restrictive	restrictive	JJ	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
paralysis	paralysis	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
hemidiaphragm	hemidiaphragm	NN	I-NP	O
diagnosed	diagnose	VBD	B-VP	O
5	5	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

=	=	SYM	O	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
HOME	HOME	NN	B-NP	O
MEDS	MEDS	NN	I-NP	O
:	:	:	O	O
Glyburide	Glyburide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
bid	bid	RB	B-ADVP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Metformin	Metformin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
bid	bid	RB	B-ADVP	O
,	,	,	O	O
Fosomax	Fosomax	NN	B-NP	O
qweek	qweek	NN	I-NP	O
,	,	,	O	O
Avandia	Avandia	NNP	B-NP	O
4mg	4mg	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
hctz	hctz	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
ADMISSION	ADMISSION	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
:	:	:	O	O
Temp	Temp	NN	B-NP	O
:	:	:	O	O
98.5	98.5	CD	B-NP	O
Supine	Supine	NN	I-NP	O
:	:	:	O	O
HR	HR	NN	B-NP	O
:	:	:	O	O
96	96	CD	B-NP	O
BP	BP	NN	I-NP	O
:	:	:	O	O
136/70	136/70	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Baseline	Baseline	NNP	I-NP	O
130	130	CD	I-NP	O
's	's	POS	B-NP	O
/	/	SYM	O	O
70	70	CD	B-NP	O
's	's	POS	B-NP	O
per	per	IN	B-PP	O
pt	pt	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Standing	Standing	NN	I-NP	O
:	:	:	O	O
HR	HR	NN	B-NP	O
:	:	:	O	O
100	100	CD	B-NP	O
BP	BP	NN	I-NP	O
:	:	:	O	O
142/72	142/72	CD	B-NP	O
RR	RR	NN	I-NP	O
:	:	:	O	O
24	24	CD	B-NP	O
O2	O2	NN	I-NP	O
Sat	Sat	NNP	I-NP	O
:	:	:	O	O
88	88	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
4L	4L	NN	I-NP	O
Gen	Gen	NN	I-NP	O
:	:	:	O	O
Fatigued	Fatigue	VBN	B-VP	O
appearing	appear	VBG	B-VP	O
,	,	,	O	O
tachypneic	tachypneic	JJ	B-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
woman	woman	NN	I-NP	O
lying	lie	VBG	B-VP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
,	,	,	O	O
pleasant	pleasant	NN	B-NP	O
,	,	,	O	O
A	A	NNP	B-NP	O
&	&	CC	I-NP	B-protein
O	O	NNP	I-NP	I-protein
x3	x3	NN	I-NP	I-protein
in	in	IN	B-PP	O
NAD	NAD	NN	B-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
nl	nl	NN	B-NP	O
conjunctiva	conjunctiva	NN	I-NP	O
,	,	,	O	O
anicteric	anicteric	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
sinus	sinus	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
PERRLA	PERRLA	NN	B-NP	O
,	,	,	O	O
EOMI	EOMI	NN	B-NP	B-protein
,	,	,	O	O
mmm	mmm	NN	B-NP	O
,	,	,	O	O
oropharynx	oropharynx	NN	B-NP	O
clear	clear	JJ	I-NP	O
Neck	Neck	NN	I-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	B-protein
9	9	CD	I-NP	I-protein
cm	cm	NN	I-NP	O
,	,	,	O	O
trachea	trachea	NN	B-NP	O
midline	midline	NN	I-NP	O
,	,	,	O	O
neck	neck	NN	B-NP	O
supple	supple	NN	I-NP	O
,	,	,	O	O
thyroid	thyroid	VBD	B-VP	O
no	no	DT	B-NP	O
palpable	palpable	JJ	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
CV	CV	NN	I-NP	I-protein
:	:	:	O	O
nl	nl	NN	B-NP	B-protein
S1	S1	NN	I-NP	I-protein
S2	S2	NN	I-NP	I-protein
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
2/6	2/6	CD	B-NP	O
high	high	JJ	I-NP	O
pitched	pitch	VBN	I-NP	O
crescendo	crescendo	NN	I-NP	O
decrescendo	decrescendo	VBP	B-VP	O
systolic	systolic	JJ	B-NP	O
murmur	murmur	NN	I-NP	O
loudest	loud	JJS	B-ADVP	O
at	at	IN	B-PP	O
upper	upper	JJ	B-NP	O
left	left	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
old	old	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	O	O
gallops	gallop	VBZ	B-VP	O
Lung	Lung	NNP	B-NP	O
:	:	:	O	O
decreased	decrease	VBN	B-NP	O
fremitus	fremitus	NN	I-NP	O
and	and	CC	I-NP	O
dullness	dullness	NN	I-NP	O
to	to	TO	B-PP	O
percussion	percussion	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
to	to	TO	B-PP	O
mid	mid	JJ	B-NP	O
lung	lung	NN	I-NP	O
,	,	,	O	O
rhonchi	rhonchi	NN	B-NP	O
heard	hear	VBD	B-VP	O
throughout	throughout	IN	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
wheezing	wheezing	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
accessory	accessory	JJ	I-NP	O
muscle	muscle	NN	I-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
good	good	JJ	B-NP	O
air	air	NN	I-NP	O
movement	movement	NN	I-NP	O
Abd	Abd	NN	I-NP	O
:	:	:	O	O
+	+	SYM	B-NP	O
BS	BS	NN	I-NP	O
,	,	,	O	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
NT	NT	NNP	B-NP	O
,	,	,	O	O
ND	ND	NNP	B-NP	O
Ext	Ext	NNP	I-NP	O
:	:	:	O	O
WWP	WWP	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
CCE	CCE	NN	I-NP	O
,	,	,	O	O
Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
MSE	MSE	NN	B-NP	O
nl	nl	NN	I-NP	O
,	,	,	O	O
CNII-XII	CNII-XII	NN	B-NP	B-protein
intact	intact	JJ	B-ADJP	O
,	,	,	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
,	,	,	O	O
negative	negative	JJ	B-NP	O
Romberg	Romberg	NN	I-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
STUDIES	STUDIES	NNS	B-NP	O
:	:	:	O	O
Chest	Ch	JJS	B-NP	O
CT	CT	NN	I-NP	B-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
embolus	embolus	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
lobar	lobar	NN	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

Limited	Limit	VBN	B-NP	O
assessment	assessment	NN	I-NP	O
of	of	IN	B-PP	O
smaller	small	JJR	B-NP	O
vessels	vessel	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
or	or	CC	B-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Mediastinal	Mediastinal	JJ	B-NP	O
and	and	CC	I-NP	O
mild	mild	JJ	I-NP	O
upper	upper	JJ	I-NP	O
abdominal	abdominal	JJ	I-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
may	may	MD	B-VP	O
warrant	warrant	VB	I-VP	O
further	far	JJR	B-NP	O
evaluation	evaluation	NN	I-NP	O
or	or	CC	O	O
follow-up	follow-up	JJ	B-NP	O
imaging	imaging	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Elevation	Elevation	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
hemidiaphragm	hemidiaphragm	NN	I-NP	O
with	with	IN	B-PP	O
associated	associate	VBN	B-NP	O
atelectasis	atelectasis	NN	I-NP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
studies	study	NNS	I-NP	O
.	.	.	O	O

=	=	SYM	O	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
CONSULTS	CONSULTS	NNS	B-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
75	75	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	B-protein
AS	AS	NN	I-NP	I-protein
,	,	,	O	O
SSS	SSS	NN	B-NP	O
s/p	s/p	NN	I-NP	O
PM	PM	NN	I-NP	O
,	,	,	O	O
DM2	DM2	NN	B-NP	B-protein
,	,	,	O	O
restrictive	restrictive	JJ	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
and	and	CC	O	O
recently	recently	RB	B-ADVP	O
several	several	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
falls	fall	NNS	B-NP	O
managed	manage	VBN	B-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
,	,	,	O	O
cardiologist	cardiologist	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
pulmonologist	pulmonologist	NN	B-NP	O
.	.	.	O	O

Workup	Workup	NNP	B-NP	O
has	have	VBZ	B-VP	O
thus	thus	RB	I-VP	O
far	far	RB	I-VP	O
been	be	VBN	I-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
causes	cause	NNS	I-NP	O
including	include	VBG	B-PP	O
new	new	JJ	B-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
,	,	,	O	O
malfunctioning	malfunction	VBG	B-VP	O
pacemaker	pacemaker	NN	B-NP	O
or	or	CC	O	O
worsening	worsen	VBG	B-VP	O
AS	AS	NN	B-NP	O
per	per	IN	B-PP	O
echo	echo	NN	B-NP	O
done	do	VBN	B-VP	O
8/18/07	8/18/07	CD	B-NP	O
at	at	IN	B-PP	O
ASCRH	ASCRH	NN	B-NP	B-protein
.	.	.	O	O

Elective	Elective	JJ	B-NP	O
cath	cath	NN	I-NP	O
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
10/15/07	10/15/07	CD	B-NP	O
at	at	IN	B-PP	O
TMC	TMC	NN	B-NP	B-cell_type
showed	show	VBD	B-VP	O
minimal	minimal	JJ	B-NP	O
CAD	CAD	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
recent	recent	JJ	I-NP	O
visit	visit	NN	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
pulmonolgist	pulmonolgist	NN	I-NP	O
two	two	CD	B-NP	O
months	month	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
revealed	reveal	VBD	B-VP	O
stable	stable	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
CXRs	CXR	NNS	I-NP	B-protein
done	do	VBN	B-VP	O
at	at	IN	B-PP	O
SBH	SBH	NN	B-NP	B-protein
suggest	suggest	VBP	B-VP	O
there	there	EX	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
presentation	presentation	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
not	not	RB	B-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
from	from	IN	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
of	of	IN	B-PP	O
valvular	valvular	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
atypical	atypical	JJ	I-NP	O
presenation	presenation	NN	I-NP	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
by	by	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
.	.	.	O	O

Given	Give	VBN	B-VP	O
her	her	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
cough	cough	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
likely	likely	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
is	be	VBZ	B-VP	O
infectious	infectious	JJ	B-ADJP	O
exacerbated	exacerbate	VBN	B-VP	O
by	by	IN	B-PP	O
her	her	PRP	B-NP	O
poor	poor	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
reserve	reserve	NN	I-NP	O
.	.	.	O	O

=	=	SYM	O	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
PULMONARY	PULMONARY	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
kept	keep	VBD	B-VP	O
on	on	IN	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
and	and	CC	I-NP	O
azithromycin	azithromycin	NN	I-NP	O
despite	despite	IN	B-PP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
CXR	CXR	NN	I-NP	B-protein
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
PT	PT	NN	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
CAP	CAP	NN	B-NP	B-protein
in	in	IN	B-PP	O
pt	pt	NN	B-NP	O
with	with	IN	B-PP	O
poor	poor	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
reserve	reserve	NN	I-NP	O
.	.	.	O	O

Presentation	Presentation	NN	B-NP	O
most	most	RBS	B-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
viral	viral	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

Symptoms	Symptom	NNS	B-NP	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
duonebs	duoneb	NNS	B-NP	O
and	and	CC	O	O
robitussin	robitussin	NN	B-NP	O
prn	prn	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
,	,	,	O	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
breathing	breathing	NN	I-NP	O
markedly	markedly	RB	B-ADVP	O
improved	improve	VBD	B-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
wean	wean	VB	I-VP	O
off	off	RP	B-PRT	O
of	of	IN	B-PP	O
O2	O2	NN	B-NP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
sat	sat	VB	I-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
without	without	IN	B-PP	O
dropping	drop	VBG	B-VP	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
below	below	IN	B-PP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
d/c	d/c	NN	B-NP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
on	on	IN	B-PP	O
azithromycin	azithromycin	NN	B-NP	O
and	and	CC	I-NP	O
albuterol	albuterol	NN	I-NP	O
inhaler	inhaler	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
Cariac	Cariac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
toprol	toprol	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
hctz	hctz	NN	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
DM2	DM2	NN	I-NP	O
:	:	:	O	O
Oral	Oral	JJ	B-NP	O
meds	med	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	I-NP	O
pt	pt	NN	I-NP	O
switched	switch	VBD	B-VP	O
to	to	TO	B-PP	O
NPH	NPH	NN	B-NP	B-protein
+	+	CC	O	O
prandial	prandial	JJ	B-NP	O
aspart	aspart	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
FEN	FEN	NN	I-NP	O
:	:	:	O	O
low	low	JJ	B-NP	O
fat	fat	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
K/Mg	K/Mg	NN	B-NP	O
scales	scale	NNS	I-NP	O
.	.	.	O	O

Tolerated	Tolerated	NNP	B-NP	O
PO	PO	NNP	I-NP	O
's	's	POS	B-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Ppx	Ppx	NN	I-NP	O
:	:	:	O	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
with	with	IN	B-PP	O
Lovenox	Lovenox	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
sc	sc	NN	I-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

=	=	SYM	O	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
FULL	FULL	NN	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
=	=	SYM	B-NP	O
=	=	SYM	B-VP	O
ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
-	-	HYPH	O	O
We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
added	add	VBN	I-VP	O
an	an	DT	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
,	,	,	I-NP	O
Azithromycin	Azithromycin	NN	I-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
that	that	IN	B-SBAR	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
take	take	VB	I-VP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Please	Please	NN	I-NP	B-protein
take	take	VB	B-VP	O
your	your	PRP$	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
you	you	PRP	B-NP	O
were	be	VBD	B-VP	O
doing	do	VBG	I-VP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Please	Please	NN	I-NP	O
schedule	schedule	NN	I-NP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Bendickson	Bendickson	NNP	I-NP	O
in	in	IN	B-PP	O
wone	wone	NN	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Please	Please	NN	I-NP	O
return	return	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
experience	experience	VBP	B-VP	O
increasing	increase	VBG	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
pain	pain	VBP	B-VP	O
with	with	IN	B-PP	O
deep	deep	JJ	B-NP	O
inspiration	inspiration	NN	I-NP	O
,	,	,	O	O
swelling	swell	VBG	B-VP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
with	with	IN	B-PP	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
questions	question	NNS	I-NP	O
or	or	CC	I-NP	O
concerns	concern	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
Please	Please	NN	I-NP	B-protein
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
new	new	JJ	B-NP	O
mediastinal	mediastinal	JJ	I-NP	O
and	and	CC	I-NP	O
abdominal	abdominal	JJ	I-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
on	on	IN	B-PP	O
CT	CT	NN	B-NP	O
scan	scan	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
DELASANCHA	DELASANCHA	NNP	B-NP	O
,	,	,	O	O
ANTHONY	ANTHONY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SY43	SY43	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2/19/07	2/19/07	CD	I-NP	O
@	@	SYM	B-NP	O
03	03	CD	I-NP	O
:	:	SYM	I-NP	O
22	22	CD	I-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

